Seattle-based PhenoPath Laboratories Retests Nearly 3,000 Breast Cancer Specimens from Quebec Breast

Seattle-based PhenoPath Laboratories Retests Nearly 3,000 Breast Cancer Specimens from Quebec Breast Cancer Inquiry Seattle-based PhenoPath Laboratories retested nearly 3,000 breast cancer specimens from the Province of Quebec following an inquiry that suggested that there might have been testing errors resulting in incorrect treatment of some patients. (PRWEB) December 20, 2009 -- Seattle-based PhenoPath Laboratories served as the reference laboratory for a highly anticipated retesting of nearly 3,000 breast cancer specimens from the Provinc
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories